XENETIC BIOSCIENCES INC's ticker is XBIO and the CUSIP is 984015503.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $7,714 | +42.4% | 19,000 | 0.0% | 0.00% | – |
Q4 2022 | $5,417 | -45.8% | 19,000 | 0.0% | 0.00% | – |
Q3 2022 | $10,000 | -33.3% | 19,000 | 0.0% | 0.00% | – |
Q2 2022 | $15,000 | -21.1% | 19,000 | 0.0% | 0.00% | – |
Q1 2022 | $19,000 | -24.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2021 | $25,000 | -51.0% | 19,000 | -24.0% | 0.00% | -100.0% |
Q2 2021 | $51,000 | -100.0% | 25,000 | -50.0% | 0.00% | 0.0% |
Q1 2021 | $109,000,000 | – | 50,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 404,550 | $484,000 | 0.26% |
Virtu Financial LLC | 35,060 | $42,000 | 0.00% |
ROYAL BANK OF CANADA | 26,991 | $32,000 | 0.00% |
UBS Group AG | 2,772 | $3,000 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
MORGAN STANLEY | 261 | $0 | 0.00% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 16,903 | $20,000 | 0.00% |
Crewe Advisors LLC | 115 | $0 | 0.00% |
BREWIN DOLPHIN LTD | 106 | $127 | 0.00% |